3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Classical hematology
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Leukemia, Myeloid, Acute
8
Lymphoma
5
Leukemia, Biphenotypic, Acute
5
Leukemia
5
Myelodysplastic Syndromes
4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Neoplasms
2
Leukemia, Myeloid
2
Leukemia, Monocytic, Acute
2
Leukemia, Lymphoid
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Leukemia, B-Cell
2
Hematologic Neoplasms
2
Hematologic Diseases
2
Burkitt Lymphoma
2
Anemia, Refractory, with Excess of Blasts
2
Shwachman-Diamond Syndrome
1
Preleukemia
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Neoplasms by Histologic Type
1
Myeloproliferative Disorders
1
Lymphoproliferative Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Primary Effusion
1
Lymphoma, Non-Hodgkin
1
Lymphatic Diseases
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myelomonocytic, Acute
1
Interventions
Cyclophosphamide
2
thymoglobulin
1
fludarabine phosphate
1
fludarabine
1
Whole-Body Irradiation
1
Tacrolimus
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Holistic Health
1
Dexamethasone
1
Bortezomib
1
Bone Marrow Transplantation
1
Blood Specimen Collection
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anemia, Sickle Cell
×
Bone Marrow Transplantation
×
1 year
×
Clear all
NCT07145411
2025-08-28
HOPE
Ossium Health, Inc.
Recruiting
10 enrolled